Karla Kurrelmeyer is a Cardiology physician affiliated with Houston Methodist. OpenAlex indexes 55 publications with 2,200 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6550 Fannin St
Suite 1901
Houston, TX 770302717
Telephone
713-441-1100Registry record last updated 10 Jan 2017.
Clinical trials
- Novel Treatment for Diastolic Heart Failure in Women
Sponsor: Baylor College of Medicine
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Amgen Inc.Program year20252 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
87.4%Statin20.4%Atorvastatin Calcium48%Rosuvastatin Calcium41%Pravastatin Sodium9%Simvastatin2%Part D<11 patientsBeta blocker14.3%Metoprolol Succinate63%Carvedilol20%Metoprolol Tartrate7%Atenolol5%Carvedilol Er2%Labetalol Hcl2%Nebivolol Hcl2%Part D<11 patients+ 19 more classes in this area
Blood & clotting
8.5%Factor Xa inhibitor6.2%Eliquis87%Xarelto13%Part D<11 patientsP2Y12 inhibitor1.8%Clopidogrel100%Part D≥27 patients+ 1 more class in this area
Metabolism & gastrointestinal
4.1%SGLT2 inhibitor2.8%Jardiance92%Farxiga9%Part D<11 patientsProton pump inhibitor0.9%Pantoprazole Sodium63%Omeprazole37%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Estrogen-Deficiency Degrades Left Ventricular Diastolic Function and Energy Metabolism in Hypertensive Female Mice
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Spectrum of Ischemic Heart Disease Throughout a Woman’s Life Cycle
Methodist DeBakey Cardiovascular Journal
2024 - A CASE OF GENOTYPE POSITIVE HYPERTROPHIC CARDIOMYOPATHY WITH HYDROXYCHLOROQUINE CARDIOMYOPATHY - A PERPLEXING OVERLAP
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Bita Esmaeli, MD
Houston Methodist
Sherif Nagueh, MD
Houston Methodist
Neal Kleiman, MD
Houston Methodist
Miguel Quinones, MD
Houston Methodist
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”